TSS
CRVS icon

Two Sigma Securities’s Corvus Pharmaceuticals CRVS Stock Holding History

Two Sigma Securities’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,384
Closed -$20.7K – 3047
2024
Q2 		$20.7K Buy
+11,384
New +$21.2K ﹤0.01% 2692
2023
Q4 		– Sell
-11,232
Closed -$16.4K – 3162
2023
Q3 		$16.4K Buy
+11,232
New +$23.8K ﹤0.01% 2606
2022
Q3 		– Sell
-11,355
Closed -$11K – 2730
2022
Q2 		$11K Buy
+11,355
New +$13.9K ﹤0.01% 2035
2021
Q4 		– Sell
-22,789
Closed -$110K – 1637
2021
Q3 		$110K Buy
+22,789
New +$67.5K 0.02% 1297

Other funds holding CRVS

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
SC
Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GTC
Ghost Tree Capital New York $276M AUM 70.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return